Sponsor pipeline

Xijing Hospital of Digestive Diseases clinical trial pipeline

Get alerts when Xijing Hospital of Digestive Diseases's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Early Phase 1
1
Phase 2/3
2
Phase 3
4
Phase 4
4
Not charted: 9 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07182890 Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With… Functional Dyspepsia Recruiting 2026-10-13
NCT07550673 Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative… Acute Severe Ulcerative Colitis Recruiting 2026-04-24
NCT07129460 Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia Gastric Intestinal Metaplasia Not Yet Recruiting 2025-09-04
NCT06523764 Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori… Helicobacter Pylori Infection Chronic Gastrit Active, Not Recruiting 2025-07-03
Phase 3
NCT05751967 Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary… Primary Biliary Cholangitis Recruiting 2026-01-08
NCT06755151 Fenofibrate in Primary Biliary Cholangitis: a Real World Study Primary Biliary Cholangitis (PBC) Recruiting 2026-01-08
NCT06755541 Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a… Primary Biliary Cholangitis (PBC) Recruiting 2026-01-08
NCT07296458 FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy Primary Biliary Cholangitis (PBC) Recruiting 2025-12-29
Phase 2/3
NCT05749822 Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis Primary Biliary Cholangitis Recruiting 2026-01-08
NCT06365424 Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) Primary Biliary Cholangitis Recruiting 2025-07-02
Early Phase 1
NCT07104201 Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) Primary Biliary Cholangitis (PBC) Active, Not Recruiting 2026-07-29
Not applicable
NCT06924489 Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy Colorectal Adenoma Recruiting 2026-08-18
NCT06092281 Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic… Patient Compliance Recruiting 2026-08-17
NCT07401303 Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time Early Gastric Cancer or Gastric Adenoma Recruiting 2026-08-17
NCT07344402 Optimization of taVNS Intervention Strategies for Refractory Constipation Refractory Constipation Recruiting 2026-01-15
NCT07323407 Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic… Functional Constipation (FC) Recruiting 2026-01-09
NCT05356520 Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric… Siewert Type II Adenocarcinoma of Esophagogastric Junction Recruiting 2024-11-08
NCT07257588 The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD Ulcerative Colitis Enrolling by Invitation 2025-12-02
Not specified
NCT06221722 Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity… Constipation - Functional Recruiting 2025-07-24
NCT06962020 Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in… Ulcerative Colitis (UC) Recruiting 2025-07-03

Disease areas by active trials

Get alerts when Xijing Hospital of Digestive Diseases's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free